Although the blockade of IL-17A signaling alleviates tissue damage and inflammation during virus infection in murine models, targeting IL-17A alone has limited efficacy in repairing the tissue damage caused by influenza A virus infection (14). This evidence concerns the gene IL17A and viral infectious disease.